Novavax launches coronavirus vaccine authorization application process in Britain, the United States and other countries

The Wall Street Journal reported on February 5 that Novavax said on Thursday that the company had initiated application procedures in the United States, Canada, the United Kingdom and the European Union to seek government approval for the use of the coronavirus vaccine developed by the company.

Novavax said it has applied to start a “rolling review” process in the country that said, which is, to begin to provide information about the coronavirus vaccine to regulators in stages.

Novavax said that in the process of reviewing the vaccine, the company can continue to complete the third phase of trials in the United Kingdom and the United States.